Cromos Pharma

Name: Cromos Pharma
Address: US Bancorp Tower, 111 S. W. Fifth Avenue, Suite 3150, Portland, OR, 97204, US
Telephone: +15034443463

Cromos Pharma is an international research organization (CRO) specializing in clinical trials. Find out more by visiting www.cromospharma.com.

Established in 2004, Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 15 years' experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and ex

cellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe. Its US base is in Portland, Oregon with additional operations in South Florida and its European HQ is situated in Dublin, Ireland.

06/18/2026

This week, the International Clinical Trials Day event at the Medical University of Warsaw brought together clinical research professionals, investigators, research centers, institutions, and industry organizations for a day of insightful discussions, networking, and collaboration.

Cromos Pharma was well represented at the event by our growing team in Poland. Throughout the day, our colleagues participated in numerous meetings and conversations, exchanged perspectives with industry peers, and strengthened relationships across the clinical research community.

We are also proud to share that Magda Kłosowska, Regional Clinical Manager for Europe at Cromos Pharma, served as a jury member for the Leaders of Clinical Research Contest, recognizing outstanding professionals in the field of clinical research.

A special thank you to Irina Burda, Jolanta Sendal, Agata Rudzka, Justyna Nowak, and Michał Frączek for their engagement, expertise, and contribution throughout the event.

As our presence in Poland continues to grow, events like these provide valuable opportunities to strengthen relationships, share expertise, and stay closely connected to one of Europe's most active clinical research markets.

06/17/2026

We are pleased to share that Nicole Brenna, US Business Development Director at Cromos Pharma, will be attending the BIO International Convention 2026, taking place from June 22 to 25 in San Diego, CA.

As the largest and most comprehensive global event in biotechnology, BIO provides a unique platform for building partnerships, exploring innovation, and advancing the future of drug development. Nicole looks forward to connecting with industry leaders and discussing how Cromos Pharma’s tailored clinical trial solutions can support and accelerate your development programs.

To connect with Nicole during BIO 2026 or to learn more about how Cromos Pharma can support your clinical development needs, contact us at [email protected]

06/11/2026

As clinical trial protocols become more complex, sponsors face an important challenge: ensuring that every measurement serves a purpose.

In this article, Cromos Pharma CEO Vlad Bogin, MD, FACP, explores the growing issue of endpoint expansion and why endpoint discipline may be critical to better study outcomes and decision-making.

Read the article: https://cromospharma.com/the-endpoint-bubble-why-clinical-trials-are-drowning-in-measurements-that-don-t-matter/

06/08/2026

Cromos Health Week has come to an end, and what a great week it has been.

Over the past several days, more than 100 colleagues from across our global team shared the activities that help them recharge, stay active, and make time for themselves outside of work. From cycling, paddleboarding, horseback riding, hiking, skiing, and table tennis to simply enjoying the outdoors with family and friends, the stories reflected a wide range of passions, routines, and healthy habits.

What stood out most was the reminder that there is no single formula for wellbeing. For some, it's an early morning workout. For others, it's time in nature, a favorite hobby, or quality moments with loved ones. The common thread is making space for the things that help us feel our best.

At Cromos Pharma, we are passionate about improving patients' lives through clinical research. Just as importantly, we recognize the value of supporting a healthy, engaged, and resilient team.

A big thank you to everyone who participated and shared a glimpse into what keeps them energized and inspired.

Here are just a few moments from Cromos Health Week.

06/05/2026

ASCO 2026 showcased remarkable advances across oncology, but several broader trends stood out beyond the individual study results.

In this article, Cromos Pharma CEO Vlad Bogin, MD, FACP shares five developments that he believes could have the greatest impact on the future of cancer research and clinical development.

Read the article: https://cromospharma.com/asco-2026-five-trends-that-caught-my-attention/

06/01/2026

Greetings from ASCO 2026.

Cromos Pharma's CEO, Vlad Bogin, MD, FACP, is on the ground in Chicago, joining discussions with sponsors, investigators, and industry leaders from around the world.

ASCO is always a great reminder of what makes this industry so special: brilliant minds, groundbreaking science, and a shared commitment to improving the lives of patients.

05/28/2026

AI is no longer viewed simply as a tool for operational efficiency in clinical trials.

The FDA is increasingly positioning AI as part of the clinical development infrastructure itself, with growing focus on governance, oversight, transparency, and regulatory trust.
In this article, we explore what the FDA’s recent initiatives could mean for the future of clinical research and why the industry may be entering a new phase of AI adoption.

Read more: https://cromospharma.com/fda-ai-and-the-future-of-clinical-trials/

05/27/2026

Poland is no longer just a cost-driven clinical research destination.

With strong oncology patient access, experienced investigators, growing infrastructure, and increasing operational maturity, the country is becoming a strategic market for European oncology trials.

In this article, Magda Klosowska, Regional Clinical Manager for Europe at Cromos Pharma, shares why sponsors should rethink Poland’s role in oncology clinical development.

Read more: https://cromospharma.com/cro-in-poland-why-poland-is-becoming-a-core-country-for-oncology-clinical-trials-in-europe/

05/26/2026

We’re pleased to share that Nicole Brenna, US Business Development Director at Cromos Pharma, will be attending the BIO International Convention 2026, taking place June 22–25 in San Diego, CA.

BIO is one of the leading global biotechnology events, bringing together professionals across biotech, pharma, clinical research, and healthcare innovation. The convention offers valuable opportunities for networking, partnership development, and discussions on the future of life sciences.

Nicole is looking forward to meeting with industry colleagues and discussing how Cromos Pharma supports global clinical development programs across a wide range of therapeutic areas.

If you will be attending BIO 2026 and would like to connect, please contact us at [email protected]

05/22/2026

As Memorial Day weekend begins, Cromos Pharma takes a moment to honor and remember the brave men and women who gave their lives in service to their country.

We sincerely thank them for their sacrifice, courage, and dedication. Wishing everyone a safe and meaningful holiday weekend.

Address

US Bancorp Tower, 111 S. W. Fifth Avenue, Suite 3150
Portland, OR
97204

Telephone

+15034443463

Website

http://www.cromospharma.com/

Alerts

Be the first to know and let us send you an email when Cromos Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed Business in Portland?